Cargando…

Association of COVID-19 Outbreak with Changes in Physical Activity Among Adults with Elevated Risk for Major Adverse Cardiovascular Events

Detalles Bibliográficos
Autores principales:	Waddell, Kimberly J., Volpp, Kevin G., Chokshi, Neel P., Small, Dylan S., Russell, Louise B., Reale, Catherine, Patel, Mitesh S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Concise Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997555/ https://www.ncbi.nlm.nih.gov/pubmed/33772441 http://dx.doi.org/10.1007/s11606-021-06725-5

Ejemplares similares

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)
por: Mielnik, Pawel, et al.
Publicado: (2023)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022)

Dentistry and the COVID-19 Outbreak
por: Amante, Luís Filipe Lima Sobral, et al.
Publicado: (2020)

The Monkeypox Outbreak and Implications for Dental Practice
por: Samaranayake, Lakshman, et al.
Publicado: (2022)

Rhizobium radiobacter pseudo-outbreak linked to tissue-processing contamination
por: Stern, Rebecca A., et al.
Publicado: (2023)

Outbreak of extensively drug-resistant Serratia marcescens in an intensive care unit
por: Vanni, Tazio, et al.
Publicado: (2023)

Uncommon Adverse Drug Reaction to a Commonly Used Antihypertensive
por: Soni, Rajesh, et al.
Publicado: (2020)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023)

Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis
por: Bomze, David, et al.
Publicado: (2022)

Glycopyrrolate-Induced Black Hairy Tongue
por: Prabha, Neel, et al.
Publicado: (2020)

Enfortumab Vedotin-Induced Toxic Epidermal Necrolysis: A Rare Fatal Adverse Reaction
por: Bansal, Aditi, et al.
Publicado: (2022)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
por: Ang, Lawrence, et al.
Publicado: (2017)

Elevated levels of sCD48 are inversely correlated with markers of disease activity in bullous pemphigoid
por: Treco, Emma, et al.
Publicado: (2022)

Molecular epidemiology of Clostridioides difficile isolates in a non-outbreak setting at a comprehensive cancer center
por: Mehta, Neha, et al.
Publicado: (2023)

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review
por: Poudel, Ishan, et al.
Publicado: (2019)

Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
por: Tu, Wen-Jun, et al.
Publicado: (2020)

The Role of Behavioral Economics in Improving Cardiovascular Health Behaviors and Outcomes
por: Hare, Allison J., et al.
Publicado: (2021)

HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks
por: Prins, Henrieke A.B., et al.
Publicado: (2023)

Rapid response to a coronavirus disease 2019 (COVID-19) outbreak in a psychiatry hospital—Kanazawa City, Japan, March to April 2020
por: Kato, Hirofumi, et al.
Publicado: (2022)

Evaluation and Monitoring of Patients With Cardiovascular Implantable Electronic Devices Undergoing Noncardiac Surgery
por: Sklyar, Eduard, et al.
Publicado: (2017)

Resurgence of human coronavirus OC43 at a long-term care facility during the coronavirus disease 2019 (COVID-19) pandemic: Outbreak investigation
por: Ohyama, Koji, et al.
Publicado: (2023)

An All-Payer Risk Model for Super-Utilization in a Large Safety Net System
por: Ziring, Jeremy, et al.
Publicado: (2018)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

Carriage of vancomycin-resistant Enterococcus faecium in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization
por: Schechner, Vered, et al.
Publicado: (2023)

Preventing adverse cutaneous reactions from amplified hygiene practices during the COVID-19 pandemic: how dermatologists can help through anticipatory guidance
por: MacGibeny, Margaret A., et al.
Publicado: (2020)

An integrative multi‐omic analysis reveals a major metabolic rewiring between baby foreskin keratinocytes and adult female abdominal keratinocytes
por: Mangez, Claire, et al.
Publicado: (2021)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Combining Cell Technologies With Biomimetic Tissue Engineering Applications: A New Paradigm for Translational Cardiovascular Therapies
por: Motta, Sarah E, et al.
Publicado: (2023)

Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive
por: Madden, Gregory R., et al.
Publicado: (2018)

Mesenchymal stromal cell‐derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application
por: Allan, David, et al.
Publicado: (2019)

The Adverse Cutaneous Effects of Hand Hygiene Practices among Individuals Other than Non-Healthcare Providers During Coronavirus-19 Pandemic: A Cross-Sectional Online Survey
por: Jindal, R., et al.
Publicado: (2021)

Human mesenchymal stromal cells and derived extracellular vesicles: Translational strategies to increase their proangiogenic potential for the treatment of cardiovascular disease
por: Nazari‐Shafti, Timo Z., et al.
Publicado: (2020)

Factors associated with uptake of guideline-recommended cardiovascular implantable electronic device management: a nationwide, retrospective cohort study
por: Young, Sara, et al.
Publicado: (2023)

Looking Back While Thinking Forward: Institutional Best Practices to Address Hospitalist Well-being During COVID-19
por: Murphy, Elizabeth, et al.
Publicado: (2023)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_imo9clek8j8jkpg469dblp0cg9